Talk to Robyn
00 1 718 213 49 04
Search inside this page
Top countries
Publication dates
Publishers
All regions
data types
Free Market Research Guides to Download
» Purchase Premium Reports
31-70 of about 4 800 reports
PharmaPoint: Multiple Sclerosis - United Kingdom Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Multiple Sclerosis - United Kingdom Drug ...
PharmaPoint: Multiple Sclerosis - Japan Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Multiple Sclerosis - Japan Drug Forecast and Market ...
Introduction Analysing the Prostate Cancer market landscape The Prostate Cancer market has seen a number of progressive changes in recent years. The launches of Johnson & Johnson's Zytiga (abiraterone ...
PharmaPoint: Multiple Sclerosis - Italy Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Multiple Sclerosis - Italy Drug Forecast and Market ...
PharmaPoint: Multiple Sclerosis - Spain Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Multiple Sclerosis - Spain Drug Forecast and Market ...
PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Multiple Sclerosis - China Drug Forecast and Market ...
PharmaPoint: Multiple Sclerosis - Canada Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Multiple Sclerosis - Canada Drug Forecast and ...
PharmaPoint: Multiple Sclerosis - India Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, ?PharmaPoint: Multiple Sclerosis - India Drug Forecast and Market ...
The nephrology and urology devices market report analyzes current dynamics and trends in the global nephrology and urology devices market for the period 2010 - 2018 and gives a forecast of the market from ...
This report analyzes the worldwide markets for Digital Pathology Systems in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of ...
MediPoint: Predictive Breast Cancer Gene Testing - APAC Analysis and Market Forecasts Summary Breast cancer is the most common form of cancer in women in both the developed and developing world. The ...
MediPoint: Predictive Breast Cancer Gene Testing - South America Analysis and Market Forecasts Summary Breast cancer is the most common form of cancer in women in both the developed and developing world. ...
MediPoint: Predictive Breast Cancer Gene Testing - EU Analysis and Market Forecasts Summary Breast cancer is the most common form of cancer in women in both the developed and developing world. The incidence ...
MediPoint: Predictive Breast Cancer Gene Testing - US Analysis and Market Forecasts Summary Breast cancer is the most common form of cancer in women in both the developed and developing world. The incidence ...
EpiCast Report: Dry Eye Syndrome - Epidemiology Forecast to 2022 Summary Dry eye syndrome, also known as keratoconjunctivitis sicca (KCS), is a multi-factorial disease of the eye caused by dryness, decreased ...
EpiCast Report: Psoriasis - Epidemiology Forecast to 2022 Summary Psoriasis is an immune-mediated chronic disorder of the skin characterized by redness and irritation. It affects people of both sexes ...
EpiCast Report: Pediatric Respiratory Syncytial Virus Infection and Prophylactic Populations in the US - Epidemiology Forecast to 2022 Summary Respiratory syncytial virus (RSV) is one of the most common ...
EpiCast Report: Dermatophytic Onychomycosis - Epidemiology Forecast to 2022 Summary Dermatophytic onychomycosis (DO) is an infection of the nail fold or nail plate with dermatophytes, a type of fungus, ...
EpiCast Report: Non-Small Cell Lung Cancer (NSCLC) - Epidemiology Forecast to 2022 Summary Lung cancer is a disease of uncontrolled cell growth in the lung tissues. It is one of the most commonly occurring ...
EpiCast Report: Hepatitis C Virus - Epidemiology Forecast to 2022 Summary Hepatitis C is a largely asymptomatic liver disease caused by the hepatitis C virus (HCV). HCV is an escalating public health ...
EpiCast Report: Meningococcal Disease - Epidemiology Forecast to 2022 Summary Meningococcal disease is caused by Neisseria meningitidis, which is an encapsulated, Gram-negative bacterium that has an ...
MediFocus: Medical Devices for the Treatment of Obesity Summary The obesity treatment market is drastically underserved and considerably underdeveloped. While bariatric surgery has significant improvement ...
EpiCast Report: Cystic Fibrosis - Epidemiology Forecast to 2022 Summary Cystic fibrosis (CF) is the most common inherited rare disease in North America and Europe, with more than 27,000 cases in the ...
EpiCast Report: Chronic Myeloid Leukemia - Epidemiology Forecast to 2022 Summary Chronic Myeloid Leukemia (CML) is a rare cancer of the white blood cells characterized by increased and unregulated growth ...
Executive Summary "Analytical Tool: Lymphoma" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in lymphoma R&D and business development. It is also a map ...
Analytical Tool - Lung Cancer is a premium combo product of "Lung Cancer: A Decision Support Tool for Optimizing the Pipeline from Research To Market" and "Lung Cancer Drug Pipeline Update 2013". According ...
"Analytical Tool - Melanoma" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in melanoma R&D and business development. It is at the same time a map of the ...
"Analytical Tool - Breast Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in breast cancer R&D and business development. It is at the same time a ...
"Analytical Tool - Colorectal Cancer" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in colorectal cancer R&D and business development. It is at the same ...
"Analytical Tool - Leukemia" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in leukemia R&D and business development. It is at the same time a map of the ...
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research
» Download Public Reports
About 17 000 reports
... Involved, even indirectly, with an important therapeutic area that addresses the needs of millions of patients who suffer from respiratory disease is particularly meaningful to all of us at elan." Relvar ...
» Read our Company Profiles
About 200 CompaniesReportlinker.com © Copyright 2013. All rights reserved.